Friday, 11 September 2015

Male impotence drug Viagra makes it hard for Malaria to spread


viagraThe hugely popular erectile dysfunction medication Viagra (sildenafil citrate) has been taken by men all around the world for over 15 years to help stiffen erections for sex, and it seems this very stiffening prowess has been found to be the key element in aiding a decreased risk in the transmission of the mosquito-borne malaria parasite Plasmodium from humans to mosquitoes. In turn, this would then prevent a further passing of the virus to other people.
The findings have been laid bare in a study conducted by the London School of Hygiene and Tropical Medicine in collaboration with the CNRS, INSERM, Université Paris Descartes at the Institut Cochin and the Institut Pasteur.
How the malaria transmission can be blocked through then use of Viagra was explained by study co-author David Baker, Professor of Malaria Parasite Biology at the London School of Hygiene and Tropical Medicine.
He said: “In this new study we show that Viagra, a drug shown to be safe in humans, can make the sexual forms of the malaria parasite stiff.
“This causes them to be inactivated in the spleen and so prevents transmission of the sexual malaria parasites to mosquitoes. This is an interesting proof of concept which gives us hope that new drugs could be developed that specifically target the malaria parasite phosphodiesterase enzymes and block malaria transmission,” he added.
Plasmodium falciparum is one of the parasites that triggers the infectious, and sometimes deadly disease malaria. This parasite isn’t always easy to treat, with experts believing the single celled organism is evolving to become more resistant to the most commonly prescribed antimalarials. It is this reason why researchers continually look for other ways to fight the disease.
The parasite develops in a person’s red blood cells, which are emitted by bone marrow into the blood stream. Should a mosquito bite somebody that is already infected, it will extract some of the parasites within the blood and there is a risk that the mosquito could then infect another person by biting them.
As the blood circulates, stiff, old or abnormal blood cells are taken in by the spleen, with the healthier normal cells left to travel around. With the Viagra though, the infected red blood cells are taken in by the spleen – meaning they are not available for mosquitoes to get after biting someone. Sildenafil maintains a signalling pathway within the red blood cells, which results in the molecule cAAMP becoming more concentrated and the cells stiffening.
So far, tests have only been conducted using test tubes and there will need to be carried out with animals. If those show signs of success the next trials will need to involve humans before any medication can be approved for the use of malaria prevention.

medical-specialists.co.uk

Female Viagra drug Flibanserin on the cusp of FDA approval


female viagraSince Pfizer’s male impotence wonder drug Viagra first burst onto the scene an incredible 17 years ago, it was subsequently joined by Eli Lily’s Cialis and Bayer’s Levitra by 2003.
Over the next 12 years the industry has witnessed variations on these such as the lower-strength Cialis Daily tablets for the more ‘active’ male and Levitra orodispersible tablets – especially suitable for men who aren’t comfortable with swallowing pills, wanting to take it with some discretion and without the requirement of a glass of water.
Men also have the options of the newer erectile dysfunction treatment Spedra (Avanafil) or Vitaros cream – ideal for men that have not experienced success with the aforementioned PDE5 inhibitor tablets or cannot take PDE5s for medical reasons.
If all that wasn’t enough choice, men suffering with premature ejaculation have over-the-counter premature ejaculation treatments such as Stud 100 Spray, condoms containing benzocaine like Durex Performa (to prolong climax), whilst there is also prescription medication such as Priligy, which is taken orally and works to prolong a man’s sexual performance by an average of 200% to 300%.
Simply put, men are spoilt for choice when it comes to finding the right treatment option for sexual dysfunction, whether this be for persistent impotence or premature ejaculation problems.
So, what is there for women? If Medical Specialists® Pharmacy were to quiz our thousands of patients to come up with the name of an existing female sexual dysfunction treatment, we’d be surprised if anyone could muster a reply.
In early 2014 Medical Specialists® reported how British pharmaceutical company ORLIBID were developing a drug tentatively titled ‘ORL101’, aimed at boosting a woman’s sex drive, however no further information has been released about ORL101 since then.
However, Medical Specialists® are delighted to announce that a new pill to boost a woman’s libido could be one step closer after US experts gave its endorsement. This will be fantastic news for those that have fought for women’s sex drives to get a similar medical attention to deal put into it as the male treatments.
A panel of Food and Drug Administration (FDA) advisers decided to vote 18-6 in favour of recommending flibanserin, a daily pill nicknamed the ‘female Viagra’ and manufactured by Sprout Pharmaceuticals, who picked up the drug back in 2011 after its initial developer, Boehringer Ingelheim, decided to drop it.
The vote came following a testimony from various women who vigorously persuaded the agency to approve the drug and told of their fear of never being able to have sex again. The final judgement of course will have to come from the FDA themselves, with a verdict on suitability for public use due later this year.
Coincidentally, flibanserin, just like the discovery of Viagra, was an unintended find. The drug was firstly developed with the intention of treating depression, but wasn’t as effective for this purpose as expected.
Many of the 11,000 women involved in the trials did note that they were experiencing some rather unexpected side effects from the flibanserin. Increased sexual interest and overall, more satisfying sexual experiences than previous, were being commonly reported.
North Carolina drug maker Sprout Pharmaceuticals, have claimed that their clinical trials have demonstrated that women have experienced a 37% rise in sexual desire in comparison to a placebo. The women reported an average of between 0.5 and one more sexually satisfying events each month, compared to those women taking a placebo. In addition, they had higher scores on questionnaires on desire and scored lower on questions about stress.
The drug – which changes brain chemistry as opposed to Viagra increasing blood flow – isn’t without a chequered history though, with the FDA twice rejecting the drug since 2010, arguing flibanserin’s benefits did not outweigh the risks, which can include low blood pressure and fainting spells.
However, Susan Scanlan, chairwoman of Even The Score, hit back and noted that Viagra can have varying side effects, arguing that the FDA hasn’t approved flibanserin because of their discomfort with women taking control over their sexuality. “The implication is that men can be trusted to make a rational decision of risk versus reward and women can’t,” she said.
The FDA has highlighted female sexual dysfunction as one of 20 priority areas of unmet medical need, and is obviously a major and genuine health problem that needs to be addressed.
Keep checking the Medical Specialists® NHS Pharmacy website for further updates about flibanserin or other female sexual dysfunction products that may become available in the future, and we already have an extension range of male impotence and premature ejaculation treatments, some of which were mentioned earlier.

Medical-specialists.co..uk

UK seizure of £15.8 million worth of counterfeit and unlicensed medicines and devices


counterfeit drugsToday (18 June) The Medicines and Healthcare products Regulatory Agency (MHRA) announced that a staggering haul of fake and unlicensed medicines and devices have been seized across Britain as part of an ongoing global operation.
The huge haul totals around £15.8 million and the seizures represent the biggest to be recorded in the UK. The types of drugs to be counterfeited include massive amounts of the usual suspects that are often imitated; erectile dysfunction and slimming pills, in addition to anaemia and narcolepsy tablets. Fake condoms and unlicensed foreign medicines were also seized.
The MHRA instigated the ‘Operation Pangea VIII’ initiative with INTERPOL, carrying out a series of worldwide drug raids during the week of 9 and 16 June, leading to 156 arrests in numerous different countries.
In news that comes as a delight to Medical Specialists®, after ourselves publishing several articles on how to spot an illegal website/fake ‘pharmacy’, Operation Pangea VIII also involved the shutting down of illicit websites that were duping customers with falsified, counterfeit and unlicensed medicines.  These websites were hit with a closure or suspension by removal of their domain name or payment facility.
Closer to home the MHRA enforcement officers joined forces with local police to conduct raids on known suspect addresses across Britain, addresses connected to the illegal online supply of potentially deadly medicines.
This led to a seizure of nearly 6.2 million doses of falsified, counterfeit and unlicensed medicines in the UK, 15,000 of which were found to be medical devices that had an estimated total value of £15.8 million. Thanks to UK operations, 1,380 websites were shut down, 339 being domestic sites.
MHRA Head of Enforcement, Alastair Jeffrey, said: “Operation Pangea is the global response to internet-facilitated medicines and devices crime. As a result of our intelligence-led enforcement operations we have seized £15.8 million worth of counterfeit and unlicensed medicines and 15,000 devices in the UK alone – which is almost twice as much as we recorded last year, and clear evidence that this is a growing concern that has to be taken seriously.
“Criminals involved in the illegal supply of medical products through the internet aren’t interested in your health – they are interested in your money and are able to get this by selling you a potentially dangerous product, or by stealing your bank details. To protect your health, visit your GP, get a correct diagnosis and buy medicines from a legitimate high street or registered pharmacy which can trade online.”
Most of the products seized in UK were imported from overseas, with India, China, Hong Kong and Singapore being the main countries in question.
With crooks always looking at new means to target potential customers, this has resulted in the MHRA investigating YouTube accounts and videos – leading to over 320 videos being taken off the site.
On a more global scale, regulators and custom officials analysed almost 150,000 packages and seized in excess of 20.7 million doses of unlicensed and counterfeit medicines, worth about £51.6 million.
Alex Lawther, from Border Force’s postal command, added: “Border Force regularly detects and seizes illegal and restricted products imported through the postal system including fake and unlicensed medicines. Our involvement in this operation with the MHRA demonstrates our commitment to combat this form of smuggling. Our message to the public is simple – don’t buy anything online unless you are certain it comes from a legitimate source.”

Medical-specialist.co.uk

Erectile Dysfunction prescriptions soar 25% in a year


coupleJust a week ago Medical Specialists® Pharmacy dramatically lowered the prices on ALL erectile dysfunction treatments, such as Viagra, generic sildenafil, Cialis, etc., and the response in the subsequent seven days has shocked even those at Medical Specialists®.
With this huge price crash, thousands of male patients from all over the UK suffering with impotence – and indeed other countries around the globe – have been using the online consultation service to submit orders for various erectile dysfunction treatments. To give an example of the price drop, 4 x Viagra 100mg tablets were previously priced at £55.95 (Inc. delivery to mainland UK), but are now priced at just £34.95.
Perhaps many have suffered in silence for too long and finally decided to seek help from Medical Specialists®, or were simply deterred by the cost of the medications, either way it seems our staggering cost reduction to patients has resulted in a soar in requests for erectile dysfunction treatments.
It is not just at Medical Specialists® though where requests for male impotence medications are coming in thick and fast, with new figures showing that prescriptions for erectile dysfunction drugs such as Viagra soaring by over 25% within a year in the UK, as costs reduced by 85.9% with the availability of generic versions from 2013.
According to statistics from the Health and Social Care Information Centre (HSCIC), last year there was found to be 1.7 million prescriptions dispensed for sildenafil (often sold as the branded Viagra), but is also obtainable under other trade names.  The HSCIC report analyses prescriptions dispensed by community pharmacists, dispensing doctors and in GP practices.
In comparison, there were 1.4 million prescriptions of sildenafil dispensed during 2013, and just one million back in 2004. For purely sildenafil alone, it was found that prescriptions increased by 21% during the previous year.
However, drugs for other conditions have seen a large increase in prescriptions too, with HSCIC figures showing that antidepressants, which includes medications for depressive illness, generalised anxiety disorder (GAD), obsessive-compulsive disorder, and panic attacks, increased by 7.2%, with 57.1 million dispensed last year, compared to 53.3 million in 2013. That means the number of dispensed prescriptions for antidepressants has almost doubled from the 29 million dispensed in 2004.
Other HSCIC stats show that in excess of 1.06 billion drugs were prescribed across England in 2014, a rise of 3.3% on the number prescribed during 2013 and an incredible rise of 55.2% on 2004.
Another finding was that the overall net ingredient cost of prescriptions in 2014 stood at £8.85 billion, representing a 2.6% rise of 2013 and 9.6% increase over the previous 10 years.
For the eighth successive year, the most amount of money went on diabetes drugs, with a 7% increase – rising by £55.3 million from 2013 to 2014, to reach £849.1 million.
Popular cholesterol drug Atorvastatin, a treatment that helps to cut the risk of heart attacks and strokes, was discovered to have the biggest rise in the number of items dispensed, with a four million rise since 2013.

Medical-specialist.co.uk 

Erectile Dysfunction linked to undiagnosed type 2 diabetes


coupleIt can be a daunting prospect for people to pluck up the courage to go and speak to their doctor about problems related to sex, especially maybe if said doctor treats the whole family or is regarded as a friend.
This explains somewhat why Medical Specialists® Pharmacy have a patient base spanning tens of thousands; people that have come to them primarily to use the online consultation service for erectile dysfunction treatments, or for the treatment of premature ejaculation. The benefit with this service is the whole process can be done online, confidentially, efficiently, securely, without a face-to-face visit to your doctor, as everything is processed in-house at Medical Specialists® and no information passed to third-parties.
However, men suffering with problems in the bedroom should take these problems more serious, as they could be a predictor for other undiagnosed conditions, such as diabetes. Gum disease and erectile dysfunction has already been linked in previous studies.
In addition, studies have also demonstrated that erectile dysfunction could be an early warning of cardiovascular disease. However, researchers have now shown that a possibly link exists between erectile dysfunction and undiagnosed hypertension, hypercholesterolemia, as well as undiagnosed type 2 diabetes.
This according to the results from a cross-sectional survey which is featured in the July/August issue of the Annals of Family Medicine, with researchers involved in the study arguing men – especially those in middle-age – with impotence problems should be able to receive diabetes screening.
The Study’s lead researcher Dr. Sean Skeldon, from the University of Toronto in Canada, says the risks were higher in middle-aged men aged 40 to 59 years old. He commented: “The probability of having undiagnosed diabetes increased from one in 50 in men without erectile dysfunction, to one in 10 in men with erectile dysfunction.”
Results were attained by collating the data from more than 4,500 men from the United States; all over the age of 20 and participating in the National Health and Nutrition Examination Survey from 2001 and 2004. The study was conducted with the aim of trying to find if associations existed between male impotence and blood pressure, cholesterol, in addition to blood sugar. Interestingly, the researchers couldn’t seem to find a link with problems achieving or sustaining an erection to undiagnosed high blood pressure or high cholesterol.
However, the findings showed that 11.5% of the men with undiagnosed diabetes had also stated they suffered with impotence problems, with an even bigger proportion for men between the ages of 40 to 59 years old – 19% showing unusually high blood sugar.
All men– particular those middle-aged– have some degree of risk of type 2 diabetes even without a diagnosis and the researchers suggest that doctors should get not only screenings, but also the sexual histories of middle-aged men.
Type 2 diabetes has been strongly linked with both genetics and ethnicity, but an incredibly large percentage of cases of type 2 diabetes are caused by poor diet that leads to being overweight or due to obesity. With early enough lifestyle changes such as improving your diet, regular exercise and weight loss, it may just be enough to slow down or even prevent the onset of type 2 diabetes.

Medical-specialist.co.uk 

‘Female Viagra’ Addyi given FDA approval in America


addyiThe very first drug aimed at boosting sexual desire in women has been given a US Food and Drug Administration (FDA) approval.
Specifically, it will treat hypoactive sexual desire disorder (HSDD) – basically a lack of libido that leads to distress, something that is believed to affect between 5.5 million and 8.6 million women in the US.
The little pink tablets will be sold under the brand name Addyi (known generically as flibanserin), and have created plenty of controversy so far, with some questioning their efficacy, possible side-effects and just how much of a need there is for the drug which is being billed as the ‘female Viagra’.
Addyi finally managed to acquire it’s US marketing licence following a laborious third attempt, with manufacturer Sprout Pharmaceuticals hoping that the pill will work wonders for women in a similar manner to that of Pfizer’s Viagra. Viagra caused major excitement after its 1998 launch and gained plenty of celebrity endorsers – actors Michael Douglas and Jack Nicholson to name just a few.
Sprout have announced Addyi is due to be rolled out in America in mid-October, yet it remains to be seen if the company will begin to look at the UK and other European countries, with no word yet on their future plans for the drug. Before any drug is sold in Britain though, it has to receive a license from the European Medicines Agency.
The FDA’s decision to hand Addyi a US marketing licence has been met with joy by campaigners for women’s rights. Recently, the drug licensing committee sat through testimonies of women who argued that the new treatment would bring back the passion and romance of times past, however fears remain that they are simply being led up a blind alley.
For men, there is the previously mentioned famous blue diamond-shaped Viagra pill for erectile dysfunction, along with other impotence treatments such as Cialis, Levitra, Spedra, etc. and premature ejaculation treatments like Priligy and Stud 100 spray, but women have been left behind when it comes to sexual dysfunction treatments. Sprout have found success where others have failed, with Pfizer, Procter & Gamble and others all previously attempting to develop products for the treatment of low sexual desire in women.
However, there are sex and relationship therapists who believe Addyi is only moderately effective, warning it should not be used in conjunction with alcohol; “Because of a potentially serious interaction with alcohol, treatment with Addyi will only be available through certified health care professionals and certified pharmacies,” said Dr Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research. “Patients and prescribers should fully understand the risks associated with the use of Addyi before considering treatment.”
Clinical trials have previously demonstrated Addyi only gave those women that took the drug merely one extra sexually satisfying experience per month, and there are concerns the drug could cause some potentially serious side-effects.  These can include low blood pressure, nausea and fainting, but alcohol could heighten the severity of the side-effects.
The claims about Addyi being the ‘female Viagra’ could be a little misleading though…unlike Pfizer’s Viagra – which impacts bloodflow – Addyi works on brain chemicals related to mood and appetite, not to dissimilar to a class of drugs known as selective serotonin reuptake inhibitors (SSRI’s), comprising of antidepressants such as Prozac.


Medical-specialist.co.uk

Online Pharmacy urges the nation to get behind Sexual Health Week 2015


sexual health week 2015Medical Specialists® Pharmacy are proudly supporting Sexual Health Week 2015, running from 14 – 20 September.
To show their support, the Manchester-based online pharmacy has previously given away literally 1,000 of condoms to all patients that sought their help with sexual health related problems such as requesting medications like Viagra for erectile dysfunction, Priligy for premature ejaculation, treating sexually transmitted infections like chlamydia with the antibiotic Azithromycin, or female patients wishing to obtain contraception like Yasmin or Dianette.
The week-long event is run annually by the FPA (Family Planning Association) throughout England, primarily aiming to boost public understanding about the numerous sexually transmitted infections (STIs) and increase the public’s knowledge regarding all aspects of good sexual health.
For those unfamiliar with the FPA, they are a sexual health charity that have been informing the general public for more than 80 years, offering advice about sex and relationships, and enabling people to make the right choices for them. In addition, the FPA try to boost people’s confidence enough to discuss issues that previously may have been looked at as embarrassing.
Each year, the FPA focus on a different theme, with last year’s Sexual Health Week being “Contraceptive choices: beyond the morning after”, looking to bust the common myths about emergency contraception. For Sexual Health Week 2014, the FPA conducted a survey involving more than 2,000 women throughout the UK to discover more about the myths that still exist with regards to emergency contraception and found that alarmingly, many women still are not using emergency contraception following unprotected sex or if their usual contraceptive method hasn’t worked.
This year, the chosen subject is sexual wellbeing and pleasure, focusing on five different themes associated with sexual pleasure and wellbeing:
  •     Education.
  •     Older people.
  •     Learning disabilities.
  •     Separating fantasy from reality.
  •     Communication skills.
The FPA will be using the themes as a platform to discuss the reasons why a lot of people – including some health professionals – find discussing the topic of sexual pleasure an embarrassing or shameful thing.
Those looking to support Sexual Health Week should continue to check the FPA website on a regular basis for new information and advice, in addition to joining the FPA and Medical Specialists® on Twitter; @FPACharity and @MSC_NEWS respectively, also using the hashtag #SexualHealthWeek2015 to see the latest news about the week.
Moreover, don’t forget that Medical Specialists® provide numerous products and treatments for all kinds of sexual health associated issues and problems.
For instance, as mentioned previously, emergency contraception was the main theme for 2014 and Medical Specialists® can provide the emergency contraceptive pill Levonelle 1500, which if taken within three days (72 hours) of unprotected sex, will usually prevent pregnancy. However, women will need to speak to their doctor for more information about taking it within five days (120 hours) of having unprotected sex.
As everybody should know, failing to use a condom during sex – especially with new partners – can result in an unwanted pregnancy and risk contracting sexually transmitted infections (STIs). Testing for the most common STI chlamydia is normally advised on a yearly basis, or for sexually active people upon meeting a new partner. Screening for the disease is often implanted through primary care (general practices and pharmacies), community sexual and reproductive health (SRH) services (including termination of pregnancy services) and GUM clinics.
Alternatively, Medically Specialists® provide Clamelle chlamydia test kit for just £24.85 which can be used in the privacy and comfort of your own home to prevent an embarrassing visit to the GP or GUM clinic and there is no need to take any time off work.
People wishing to support Sexual Health Week can receive a campaign pack by sending a stamped, addressed A4 envelope to the value of £1.26 to: FPA Campaigns Team, 23-28 Penn Street, London N1 5DL.
In addition, for further information about sexual health you can go to Medical Specialists® website and contact our pharmacist by email, or visit the FPA website for more information about sexual health and services.


 Medical-specialist.co.uk